Joan Broussard Selected Research

Canagliflozin

11/2019

Canagliflozin-induced Fanconi syndrome in a patient with previously unrecognized type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joan Broussard Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2019
1	Chronic Renal Insufficiency 01/2020
1	Systemic Vasculitis 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Lupus Nephritis 01/2020
1	Proteinuria 01/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020
1	Acidosis 11/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2019
1	Fanconi Syndrome (Syndrome, Fanconi) 11/2019

Drug/Important Bio-Agent (IBA)

1	Hydralazine (Apresoline)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Insulin (Novolin)FDA Link 11/2019
1	ElectrolytesIBA 11/2019
1	CanagliflozinIBA 11/2019

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2019